Publications database

This page describes the EMCDDA's ongoing work on the impact of the COVID-19 pandemic on drug markets in the EU. As well as showcasing EMCDDA publications on the topic, it also provides...

On this page, the EMCDDA has compiled examples of advice being issued to people who use drugs and service providers by some national bodies and different associations, networks and NGOs. This resource...

This 2020 EMCDDA update on drug-related infectious diseases aims to provide a comprehensive overview of the current situation with regard to the epidemiological picture of drug-related infectious diseases in Europe up to...

Since the start of 2020, European countries have been experiencing an unprecedented public health threat with the emergence of the coronavirus disease (COVID-19). In order to investigate the effects and implications of...

This report is a rapid and preliminary analysis of the impact of COVID-19 on selected online markets. Three relatively large darknet markets were reviewed for the purposes of this study, selected because...

Over the past quarter of a century, the EMCDDA has expanded its monitoring capability to keep pace with revolutionary changes in the extent and nature of the drugs problem and in the...

Isotonitazene is a synthetic opioid analgesic monitored by the EMCDDA as a new psychoactive substance through the European Union Early Warning System since 2019. Based on potential public health risks, an initial...

Follow the timeline and take a walk through some of the key moments in the EMCDDA's 25 years of international cooperation.

COVID-19 is a major global health threat. People who use drugs face the same risks as those of the general population and therefore need to be aware of the appropriate advice to...

Wastewater-based epidemiology (WBE) is a rapidly developing scientific discipline with potential for monitoring real-time data on geographical and temporal trends in illicit drug use, which established itself as a useful complement to...